Federated Hermes’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-58,025
| Closed | -$19.2M | – | 2138 |
|
|
2025
Q1 | $19.2M | Buy |
+58,025
| New | +$19.2M | 0.04% | 411 |
|
|
2022
Q4 | – | Sell |
-240,000
| Closed | -$15.6M | – | 2230 |
|
|
2022
Q3 | $15.6M | Hold |
240,000
| – | – | 0.05% | 436 |
|
|
2022
Q2 | $17.2M | Sell |
240,000
-102,597
| -30% | -$7.34M | 0.05% | 427 |
|
|
2022
Q1 | $33.6M | Buy |
+342,597
| New | +$33.6M | 0.08% | 319 |
|
|
2021
Q4 | – | Sell |
-3,303
| Closed | -$264K | – | 2258 |
|
|
2021
Q3 | $264K | Sell |
3,303
-2,599
| -44% | -$208K | ﹤0.01% | 1619 |
|
|
2021
Q2 | $575K | Buy |
+5,902
| New | +$575K | ﹤0.01% | 1477 |
|
|
2018
Q4 | – | Sell |
-18
| Closed | -$4K | – | 2260 |
|
|
2018
Q3 | $4K | Sell |
18
-4,525
| -100% | -$1.01M | ﹤0.01% | 2085 |
|
|
2018
Q2 | $1.27M | Buy |
4,543
+4,523
| +22,615% | +$1.27M | ﹤0.01% | 1202 |
|
|
2018
Q1 | $2K | Sell |
20
-266
| -93% | -$26.6K | ﹤0.01% | 2060 |
|
|
2017
Q4 | $26K | Buy |
286
+123
| +75% | +$11.2K | ﹤0.01% | 1731 |
|
|
2017
Q3 | $7K | Buy |
+163
| New | +$7K | ﹤0.01% | 1907 |
|